| Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study JB Olesen, GYH Lip, ML Hansen, PR Hansen, JS Tolstrup, J Lindhardsen, ... Bmj 342, 2011 | 1715 | 2011 |
| Association of national initiatives to improve cardiac arrest management with rates of bystander intervention and patient survival after out-of-hospital cardiac arrest M Wissenberg, FK Lippert, F Folke, P Weeke, CM Hansen, ... Jama 310 (13), 1377-1384, 2013 | 1445 | 2013 |
| Stroke and bleeding in atrial fibrillation with chronic kidney disease JB Olesen, GYH Lip, AL Kamper, K Hommel, L Køber, DA Lane, ... New England Journal of Medicine 367 (7), 625-635, 2012 | 1135 | 2012 |
| Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation ML Hansen, R Sørensen, MT Clausen, ML Fog-Petersen, J Raunsø, ... Archives of internal medicine 170 (16), 1433-1441, 2010 | 1077 | 2010 |
| Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ... The Lancet 391 (10117), 219-229, 2018 | 968 | 2018 |
| Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective … R Sørensen, ML Hansen, SZ Abildstrom, A Hvelplund, C Andersson, ... The Lancet 374 (9706), 1967-1974, 2009 | 723 | 2009 |
| Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million … TK Schramm, GH Gislason, L Køber, S Rasmussen, JN Rasmussen, ... Circulation 117 (15), 1945-1954, 2008 | 695 | 2008 |
| Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial … GH Gislason, S Jacobsen, JN Rasmussen, S Rasmussen, P Buch, ... Circulation 113 (25), 2906-2913, 2006 | 626 | 2006 |
| Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a ‘real world’nationwide cohort study JB Olesen, GYH Lip, J Lindhardsen, DA Lane, O Ahlehoff, ML Hansen, ... Thrombosis and haemostasis 106 (10), 739-749, 2011 | 619 | 2011 |
| Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction … TK Schramm, GH Gislason, A Vaag, JN Rasmussen, F Folke, ML Hansen, ... European heart journal 32 (15), 1900-1908, 2011 | 607 | 2011 |
| Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention … M Lamberts, JB Olesen, MH Ruwald, CM Hansen, D Karasoy, ... Circulation 126 (10), 1185-1193, 2012 | 547 | 2012 |
| The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study J Lindhardsen, O Ahlehoff, GH Gislason, OR Madsen, JB Olesen, ... Annals of the rheumatic diseases 70 (6), 929-934, 2011 | 521 | 2011 |
| Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study O Ahlehoff, GH Gislason, M Charlot, CH Jørgensen, J Lindhardsen, ... Journal of internal medicine 270 (2), 147-157, 2011 | 520 | 2011 |
| Duration of treatment with nonsteroidal anti-inflammatory drugs and impact on risk of death and recurrent myocardial infarction in patients with prior myocardial infarction: a … AM Schjerning Olsen, EL Fosbøl, J Lindhardsen, F Folke, M Charlot, ... Circulation 123 (20), 2226-2235, 2011 | 470 | 2011 |
| Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention M Lamberts, GH Gislason, JB Olesen, SL Kristensen, ... Journal of the American College of Cardiology 62 (11), 981-989, 2013 | 447 | 2013 |
| Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality EL Fosbøl, JH Butt, L Østergaard, C Andersson, C Selmer, K Kragholm, ... Jama 324 (2), 168-177, 2020 | 438 | 2020 |
| Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ... The Lancet 391 (10117), 205-218, 2018 | 414 | 2018 |
| Bystander efforts and 1-year outcomes in out-of-hospital cardiac arrest K Kragholm, M Wissenberg, RN Mortensen, SM Hansen, C Malta Hansen, ... New England Journal of Medicine 376 (18), 1737-1747, 2017 | 411 | 2017 |
| Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure GH Gislason, JN Rasmussen, SZ Abildstrom, TK Schramm, ML Hansen, ... Archives of internal medicine 169 (2), 141-149, 2009 | 385 | 2009 |
| Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction GH Gislason, JN Rasmussen, SZ Abildstrøm, N Gadsbøll, P Buch, ... European heart journal 27 (10), 1153-1158, 2006 | 385 | 2006 |
Christian Torp-PedersenProfessor of cardiology and clinical epidemiology, Aalborg University and department of CardiologyVerificeret mail på heart.dk
